People News

Share this article:
California-based OncoMed Pharmaceuticals, a developer focused on antibody therapeutics that target cancer stem cells, announced the appointment of Sunil Patel to SVP, corporate development. Patel will be responsible for corporate business development, and will report to Paul Hastings, president and CEO. Patel was previously VP, corporate development and marketing at BiPar Sciences, which was acquired by Sanofi-Aventis last April.

DOR BioPharma, a late-stage biopharmaceutical company based in New Jersey, tapped Christopher Schnittker as vice president of administration and controller. Schnittker will oversee accounting, human resources and other administrative functions.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.